CN1294953C - External Chinese materia medica preparation for treating leucoderma - Google Patents
External Chinese materia medica preparation for treating leucoderma Download PDFInfo
- Publication number
- CN1294953C CN1294953C CN 200510017010 CN200510017010A CN1294953C CN 1294953 C CN1294953 C CN 1294953C CN 200510017010 CN200510017010 CN 200510017010 CN 200510017010 A CN200510017010 A CN 200510017010A CN 1294953 C CN1294953 C CN 1294953C
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- treating leucoderma
- external application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides an external application Chinese medicine preparation for treating leucoderma, which is composed of black plum, Japanese ampelopsis root, psoralea, fleece-flower root, drynaria, black soybean, black sesame and liquorice root. The external application Chinese medicine is prepared with a traditional method for preparing Chinese medicine. The external application Chinese medicine preparation for treating leucoderma which is a pure Chinese medicine preparation does not stimulate skin, has an inhibiting effect on white staph bacteria, hay bacillus, trichophyton mentagrophytes, sporule bacteria, etc., and has the advantages of convenient treatment, obvious clinical effect and no recurrence after cure.
Description
Technical field
The present invention relates to treat the medicine of vitiligo disease, especially disclose the leukodermic Chinese medicine for outer use of a kind of treatment, belong to Chinese medicine pharmaceutical technology field.
Background technology
China's tcm theory thinks that leukodermic morbidity is the synergistic result of body internal and external factor.In because the liver spleen suffer from a deficiency of the kidney, how by deficiency of liver-blood, insufficiency of kidney-YANG, deficiency of kidney-QI, cause and make the body yin and yang imbalance, qi-blood disharmony.On this basis, damp and hot ailment said due to cold or exposure is taken advantage of a weak point, and the visitor goes into skin, impatency meridians blood vessels, and skin must not be warm, and skin and hair lose to be supported and to be caused the pigment cell to take off mistake, and local or whole body skin forms white macula and falls ill, and the traditional Chinese medical science is called leucoderma, erosion or vitiligo in vain.Its Therapeutic Principle serves as main the treatment with nourishing blood to expel wind, blood circulation promoting and blood stasis dispelling, medicine is vifiligo pill, loses Chinese patent medicines such as ball, vitiligo capsule in vain, but in the clinical treatment process, singly cuts with the uncertain therapeutic efficacy of a certain medicine, can only reach recent clinical effectiveness, recurrent is stronger.
The doctor trained in Western medicine theory emphasizes that then vitiligo is to disappear owing to skin pigment that the skin metabolism obstacle causes, does not still have effective Therapeutic Method at present.
Summary of the invention
The invention provides the leukodermic Chinese medicine for outer use of a kind of treatment, determined curative effect, clinical symptoms is improved obviously, cures the back and is difficult for recurrence.
To leukodermic pathogenesis and Therapeutic Principle, selected following pure Chinese crude drug is made Chinese medicine preparation: (by weight) through the scientific composition compatibility according to Chinese medicine in the present invention
55～65 parts of Fructus Mumes, 25～30 parts of Radix Ampelopsis, 40～50 parts of Fructus Psoraleaes,
20～28 parts of Radix Polygoni Multiflori, 25～30 parts of Rhizoma Drynariae, 25～30 parts of Semen sojae atricolor,
15～20 parts of Semen Sesami Nigrums, 15～20 parts in Radix Glycyrrhizae.
Optimum ratio of the present invention is:
55 parts of Fructus Mumes, 30 parts of Radix Ampelopsis, 45 parts of Fructus Psoraleaes, 20 parts of Radix Polygoni Multiflori,
30 parts of Rhizoma Drynariae, 25 parts of Semen sojae atricolor, 15 parts of Semen Sesami Nigrums, 18 parts in Radix Glycyrrhizae.
Processing procedure of the present invention is as follows:
Adopt traditional unguentum preparation method, above-mentioned each medicine is taken by weighing in proportion, clean and to be ground into 60～90 order fine powders after removing impurity, in the oil phase that the 250 parts of vaseline that slowly adds fusing and 50 parts of Adeps Sus domesticas are made, stir and all make unguentum, get pharmaceutical preparation of the present invention.
Prescription of the present invention also can be made related dose forms according to exterior-applied formulation processing procedures such as the tincture of routine, sprays.
Usage and dosage: external preparation, put on the skin repeatedly and smear site of disease, every day 3～4 times, each 3～5 minutes.
Based on Fructus Mume, Radix Ampelopsis, incarnation is controlled dead flesh among the present invention, and it is damp and hot to be apt to remove skin, sterilization detoxifcation, promoting tissue regeneration by removing blood stasis; Radix Polygoni Multiflori, Fructus Psoraleae are supported essence and blood, controlling nocturnal emission with astringent drugs gas, are improved immunity; Rhizoma Drynariae expansion local vascular improves histotrophic nutrition; Semen sojae atricolor, Semen Sesami Nigrum can promote melanin new life; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, benefiting qi and raising yang are separated hundred poison.All medicines share make microcirculation vigorous, regulate body's immunity and homeostasis, nourishing the liver and kidney, benefiting QI and nourishing blood, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, collateral dredging speckle removing are with Zhi Qiben.
The curative effect of following case proof medicine of the present invention:
Case 1
Ma, man, 38 years old, cadre, patient found that before 5 years the bilateral waist respectively has the white macula district of size as 1 Semen Glycines, observed when going to a doctor after 1 year and found that two waists, abdominal part have formed 4 2～3.5cm
2White macula, forehead, two cheek to two glabellas have 8 2～25cm of symmetrical distribution
2White macula district, the left and right sides, the patient once went to a doctor in how tame hospital, and was in taking, the Western medicine several months, all invalid.Use medicine of the present invention to put on the skin and smear site of disease, through treatment in 5 months, two cheeks, two eyebrows place white macula be the normal colour of skin of full recovery, forehead, two cheek white maculas district has a large amount of chromogenesis, and 1～20mm contracts in the edge, the normal colour of skin of 115 days back lumbar part white maculas full recovery, not recurrence so far after the consolidation.
Case 2
The Wang, the woman, 20 years old, workman, patient suffered from 3 years vitiligo time, and branch is at finger-joint, cervical region.The comprehensive about 9cm of area
2, it is invalid to seek medical advice in many ways.Use medicine of the present invention to put on the skin repeatedly and smear site of disease, through promptly growing a large amount of pigments island (being skin points) in 30 days, recovery from illness in 5 months.Now do not see recurrence so far.
Case 3
Liu, the man, 16 years old, people from Wuhan City, Hubei Province, patient fall ill, and it was 6 years, branch is at hands, face, cervical region, the comprehensive about 3cm of area
2, belong to the type that distributes.Be to use medicine of the present invention, put on the skin repeatedly and smear site of disease, every day 3～4 times, each 3～5 minutes, treated 3 months, pars affecta skin begins the pulverize redness, and the state of an illness gets control fully, be transformed into the pigmentation point gradually, continue medication 3 months, pigmentation point enlarges gradually until recovery from illness.Followed up a case by regular visits to 6 months, and do not see rebound phenomenon.
Observe 20 routine patients altogether, cure 8 people (40%), pigment recovers fully; Produce effects 9 people (45%), pigment recovers substantially; Effective 2 people (10%), pigment partly recovers; Invalid 1 people (5%), pigment does not have change.
Good effect of the present invention is: the pure Chinese medicinal preparation prescription, and chafe does not all have inhibitory action to white staphylococcus, bacillus subtilis, trichophyton mentagrophytes, microspore bacterium etc., and treatment is convenient, and clinical effectiveness is remarkable, non-relapse after healing.
The specific embodiment
Embodiment 1
Take by weighing Fructus Mume 55g, Radix Ampelopsis 30g, Fructus Psoraleae 45g, Radix Polygoni Multiflori 20g, Rhizoma Drynariae 30g, Semen sojae atricolor 25g, Semen Sesami Nigrum 15g, Radix Glycyrrhizae 18g, clean and to be ground into 80 order fine powders after removing impurity, slowly in the oil phase that the 250g vaseline of adding fusing and 50g Adeps Sus domestica are made, stir and all make unguentum, get medicine plaster preparation of the present invention.Other should meet People's Republic of China's version pharmacopeia in 2000 plaster item.
Embodiment 2
Take by weighing Fructus Mume 65g, Radix Ampelopsis 25g, Fructus Psoraleae 50g, Radix Polygoni Multiflori 28g, Rhizoma Drynariae 30g, Semen sojae atricolor 30g, Semen Sesami Nigrum 20g, Radix Glycyrrhizae 15g, clean and to be ground into 80 order fine powders after removing impurity, add ethanol, soaked for 3 weeks with volumetric concentration 75%, filter decontamination, get external-use tincture of the present invention.Other should meet People's Republic of China's version pharmacopeia in 2000 tincture item.
Embodiment 3
With Fructus Mume 60g, Radix Ampelopsis 30g, Fructus Psoraleae 50g, Radix Polygoni Multiflori 25g, Rhizoma Drynariae 25g, Semen sojae atricolor 25g, Semen Sesami Nigrum 20g, Radix Glycyrrhizae 20g, clean and to be ground into 80 order fine powders after removing impurity, adding is with the ethanol of volumetric concentration 75%, soaked for 3 weeks, filter decontamination, pour in the pressure bottle, get external spraying agent type medicine of the present invention.Other should meet People's Republic of China's version pharmacopeia in 2000 spray item.
Claims (2)
1, the leukodermic Chinese medicine for outer use of a kind of treatment is characterized in that being made by following parts of medicines by weight:
55～65 parts of Fructus Mumes, 25～30 parts of Radix Ampelopsis, 40～50 parts of Fructus Psoraleaes,
20～28 parts of Radix Polygoni Multiflori, 25～30 parts of Rhizoma Drynariae, 25～30 parts of Semen sojae atricolor,
15～20 parts of Semen Sesami Nigrums, 15～20 parts in Radix Glycyrrhizae.
2, Chinese medicine preparation according to claim 1 is characterized in that being made by following parts of medicines by weight:
55 parts of Fructus Mumes, 30 parts of Radix Ampelopsis, 45 parts of Fructus Psoraleaes, 20 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma Drynariae, 25 parts of Semen sojae atricolor, 15 parts of Semen Sesami Nigrums, 18 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017010 CN1294953C (en) | 2005-07-29 | 2005-07-29 | External Chinese materia medica preparation for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017010 CN1294953C (en) | 2005-07-29 | 2005-07-29 | External Chinese materia medica preparation for treating leucoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1726980A CN1726980A (en) | 2006-02-01 |
| CN1294953C true CN1294953C (en) | 2007-01-17 |
Family
ID=35926618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510017010 Expired - Fee Related CN1294953C (en) | 2005-07-29 | 2005-07-29 | External Chinese materia medica preparation for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1294953C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385791B (en) * | 2008-10-27 | 2012-07-04 | 严跃华 | Leukoderma treating medicine |
-
2005
- 2005-07-29 CN CN 200510017010 patent/CN1294953C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1726980A (en) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN102228485B (en) | Composition for burn rehabilitation and preparation method thereof | |
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN102228586A (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
| CN1181844C (en) | Medicine for treating burns and scalds and its prepn process | |
| CN100434109C (en) | Medicine ointment for treating burns and scalds and its prepn | |
| CN107137471A (en) | A kind of Traditional Chinese medicine used as analgesic composition and its preparation method and application | |
| CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
| CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
| CN1294953C (en) | External Chinese materia medica preparation for treating leucoderma | |
| CN101406621B (en) | Medicinal liquor for treating sequelae of cerebral thrombus | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN100349606C (en) | Drug tincture for treating flat wart, and preparation method | |
| CN101780193A (en) | Special-effect plaster for treating fractures and various non-healing wounds | |
| CN1435223A (en) | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN1140289C (en) | Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn | |
| CN112121086A (en) | A Chinese medicinal tincture for transdermal therapy and its preparation method | |
| CN1733167A (en) | External applied Chinese traditional medicine plaster for curing facial paralysis and process for preparing the same | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN102614330A (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN1203804A (en) | Ganbingkang medicine for curing liver disease | |
| CN108283670A (en) | A kind of pharmaceutical composition and preparation method thereof for treating burn and scald | |
| CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070117 |